A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects

NCT01404091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: LY2940094

Sponsor

BlackThorn Therapeutics, Inc.